DVBCWPM1 ;ALB/ESW PULMONARY TB AND MYCO. DIS. WKS TEXT - 1 ; 10 Oct 2000
;;2.7;AMIE;**34**;Apr 10, 1995
;
TXT ;
;;A. Review of Medical Records:
;;
;;B. Medical History (Subjective Complaints):
;; Comment on:
;;
;; 1. Activity of pulmonary tuberculosis or other mycobacterial disease.
;; 2. Date of inactivity if it is not active.
;; 3. Identity of organism (if possible).
;;
;;C. Physical examination (Objective Findings):
;; Address each of the following and fully describe current findings:
;;
;; 1. Extent of structural damage to lungs.
;; 2. If patient was hospitalized for 6 months or more, what is the
;; condition at the end of hospitalization?
;; 3. If patient was hospitalized for 12 months or more, what is the
;; condition at the end of hospitalization?
;;
;;D. Diagnostic and Clinical Tests:
;;Provide:
;;
;;1. Pulmonary Function Tests, if indicated. If performed, include the results
;; in the examination report, The FEV-1,FVC, and FEV-1/FVC should be included.
;; Both pre- and post-bronchodilatation pulmonary function test results should
;; be reported. If post-bronchodilatation test is not conducted in a particular
;; case, please provide an explanation of why not. A DLCO may or may not be
;; done routinely as part of pulmonary function testing at a particular
;; facility. If there is a disparity between the results of different tests,
;; please indicate which tests are more likely to accurately reflect
;; the severity of the condition.
;;
;; DLCO note: If DLCO was not done as a routine part of pulmonary function
;; testing, the examiner should use his or her judgment, based on
;; the specific condition (.e.g., whether it is obstructive,
;; interstitial, etc.) and other available information about the condition,
;; as to whether a DLCO test is needed, since it is not useful in all
;; situations. If it may provide useful information about the severity
;; of the condition, it should be requested and reviewed before
;; the examination report is submitted. If the examiner determines that
;; the DLCO test is not needed, a statement as to why not (e.g., there are
;; decreased lung volumes that would not yield valid test results) should be
;; included in the report. Such a statement could avoid a remand from BVA
;; when the test is not done. However in the case of a BVA remand in which
;; the DLCO is requested, the DLCO MUST be done unless there is a medical
;; contraindication.
;;
;;E. Diagnosis:
;;
;; 1. In reactivated cases, is this reactivation of the old disease
;; or a separate and distinct new infection?
;;
;;ADDITIONAL NOTE TO THE EXAMINER:
;;
;;In all claims, if the disease is inactive and if the inactivity was confirmed
;;at a non-VA facility, obtain the name and mailing address of the facility
;;from the veteran so that the Regional Office may request the report.
;;
;;
;;Signature: Date:
;;END
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HDVBCWPM1 3142 printed Sep 23, 2025@19:29:38 Page 2
DVBCWPM1 ;ALB/ESW PULMONARY TB AND MYCO. DIS. WKS TEXT - 1 ; 10 Oct 2000
+1 ;;2.7;AMIE;**34**;Apr 10, 1995
+2 ;
TXT ;
+1 ;;A. Review of Medical Records:
+2 ;;
+3 ;;B. Medical History (Subjective Complaints):
+4 ;; Comment on:
+5 ;;
+6 ;; 1. Activity of pulmonary tuberculosis or other mycobacterial disease.
+7 ;; 2. Date of inactivity if it is not active.
+8 ;; 3. Identity of organism (if possible).
+9 ;;
+10 ;;C. Physical examination (Objective Findings):
+11 ;; Address each of the following and fully describe current findings:
+12 ;;
+13 ;; 1. Extent of structural damage to lungs.
+14 ;; 2. If patient was hospitalized for 6 months or more, what is the
+15 ;; condition at the end of hospitalization?
+16 ;; 3. If patient was hospitalized for 12 months or more, what is the
+17 ;; condition at the end of hospitalization?
+18 ;;
+19 ;;D. Diagnostic and Clinical Tests:
+20 ;;Provide:
+21 ;;
+22 ;;1. Pulmonary Function Tests, if indicated. If performed, include the results
+23 ;; in the examination report, The FEV-1,FVC, and FEV-1/FVC should be included.
+24 ;; Both pre- and post-bronchodilatation pulmonary function test results should
+25 ;; be reported. If post-bronchodilatation test is not conducted in a particular
+26 ;; case, please provide an explanation of why not. A DLCO may or may not be
+27 ;; done routinely as part of pulmonary function testing at a particular
+28 ;; facility. If there is a disparity between the results of different tests,
+29 ;; please indicate which tests are more likely to accurately reflect
+30 ;; the severity of the condition.
+31 ;;
+32 ;; DLCO note: If DLCO was not done as a routine part of pulmonary function
+33 ;; testing, the examiner should use his or her judgment, based on
+34 ;; the specific condition (.e.g., whether it is obstructive,
+35 ;; interstitial, etc.) and other available information about the condition,
+36 ;; as to whether a DLCO test is needed, since it is not useful in all
+37 ;; situations. If it may provide useful information about the severity
+38 ;; of the condition, it should be requested and reviewed before
+39 ;; the examination report is submitted. If the examiner determines that
+40 ;; the DLCO test is not needed, a statement as to why not (e.g., there are
+41 ;; decreased lung volumes that would not yield valid test results) should be
+42 ;; included in the report. Such a statement could avoid a remand from BVA
+43 ;; when the test is not done. However in the case of a BVA remand in which
+44 ;; the DLCO is requested, the DLCO MUST be done unless there is a medical
+45 ;; contraindication.
+46 ;;
+47 ;;E. Diagnosis:
+48 ;;
+49 ;; 1. In reactivated cases, is this reactivation of the old disease
+50 ;; or a separate and distinct new infection?
+51 ;;
+52 ;;ADDITIONAL NOTE TO THE EXAMINER:
+53 ;;
+54 ;;In all claims, if the disease is inactive and if the inactivity was confirmed
+55 ;;at a non-VA facility, obtain the name and mailing address of the facility
+56 ;;from the veteran so that the Regional Office may request the report.
+57 ;;
+58 ;;
+59 ;;Signature: Date:
+60 ;;END
